Amphion Innovations plc
Annual General Meeting Results
London and New York, 27 July 2012 – Amphion Innovations plc (LSE: AMP) (“Amphion” or the “Company”), the developer of medical and technology businesses, today announces that all resolutions were passed at the Annual General Meeting, which was held on Thursday 26 July 2012.
For further information please contact
+1 212 210 6224
+44 (0)20 7930 0777
Seymour Pierce Limited, Nominated Advisor
Freddy Crossley/Mark Percy
+44 (0)20 7107 8000
About Amphion Innovations plc
Amphion (LSE: AMP) builds shareholder value in emerging companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.
On the web: www.amphionplc.com